Chinook Therapeutics, Inc. (KDNY) — Analyst outlook / Analyst consensus target is. Based on 11 analyst ratings, the consensus is bullish — 2 Buy, 9 Hold.
The consensus price target is $30.00, representing a downside of 25.7% from the current price $40.39.
KDNY Stock — 12-Month Price Forecast
$30.00
▼ -25.72% Downside
Average Price Target
Based on 11 Wall Street analysts offering 12-month price targets for Chinook Therapeutics, Inc., the price target is $30.00.
The average price target represents a -25.72% change from the last price of $40.39.
KDNY Analyst Ratings
Hold
Based on 11 analysts giving stock ratings to Chinook Therapeutics, Inc. in the past 3 months
